NANOSPAIN

Related News

ICN2 Plasmonic Biosensor for COVID and other conditions [02-03-2022]
An innovative nano-biosensor assay for fast, quantitative and accurate COVID-19 serology, has been developed by a team of researchers led by Prof. Laura M. Lechuga, head of the NanoBiosensors and Bioanalytical Applications Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2, Barcelona, Spain). The sensor combines the high reliability of specialised laboratory analysis with the short turnaround times and simple operability of rapid self-tests.

Josep Samitier joins Fraunhofer Spain Research as Director [19-01-2026]
Nanobiotechnology, Nanomedicine, Scientific Policy

Barcelona refuerza la apuesta por la biomedicina con un centro de diagnósticos y terapias avanzadas [12-01-2026]
Nanobiotechnology, Nanomedicine

Nanoparticle therapy reprograms tumor immune cells to attack cancer from within [02-01-2026]
Nanobiotechnology, Nanomedicine

Nanozigzags, a new biomaterial, can enhance cancer immunotherapy efficacy by nearly 70% [30-12-2025]
Nanobiotechnology, Nanomedicine

Josep Samitier concludes thirteen years at the helm of IBEC [17-12-2025]
Nanobiotechnology, Scientific Policy